Lilly Breast Cancer Drug Results May Challenge Pfizer Pill

(Bloomberg) -- Eli Lilly & Co.’s experimental breast cancer drug abemaciclib, when combined with standard therapy, slowed the progression of the tumor in patients with an advanced form of the disea...

Bloomberg Quint

Add BloombergQuint App to Home screen.